Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2026
ARP2/3 complex mediates the neuropathology of PTEN-deficient human neural cells downstream of mTORC1 and mTORC2 hyperactivation
Navroop K Dhaliwal, Octavia Yifang Weng, Ai Tian, et al.
The Journal of Cell Biology
|
June 19, 2013
The tumor suppressor CDKN3 controls mitosis
Grzegorz Nalepa, Jill Barnholtz-Sloan, Rikki Enzor, et al.
American Journal of Medical Genetics. Part A
|
July 24, 2012
The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research
Maria T Acosta, Carrie E Bearden, F Xavier Castellanos, et al.
Cell Chemical Biology
|
February 9, 2023
Selective and brain-penetrant lanosterol synthase inhibitors target glioma stem-like cells by inducing 24(S),25-epoxycholesterol production
Thu P Nguyen, Wentian Wang, Alex C Sternisha, et al.
Cell
|
November 6, 2008
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow
Feng-Chun Yang, David A Ingram, Shi Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 10, 2025
Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors
Sameer Farouk Sait, Kwan Ho Tang, Steven P Angus, et al.
Nature
|
November 20, 2024
Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma
Yu-Jung Chen, Swathi V Iyer, David Chun-Cheng Hsieh, et al.
American Journal of Medical Genetics. Part A
|
November 14, 2014
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues
Katherine A Rauen, Susan M Huson, Emma Burkitt-Wright, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation
Laura Biddlestone-Thorpe, Muhammad Sajjad, Elizabeth Rosenberg, et al.
American Journal of Medical Genetics. Part A
|
January 29, 2011
Back to the future: proceedings from the 2010 NF Conference
Susan M Huson, Maria T Acosta, Allan J Belzberg, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2026
ARP2/3 complex mediates the neuropathology of PTEN-deficient human neural cells downstream of mTORC1 and mTORC2 hyperactivation
Navroop K Dhaliwal, Octavia Yifang Weng, Ai Tian, et al.
The Journal of Cell Biology
|
June 19, 2013
The tumor suppressor CDKN3 controls mitosis
Grzegorz Nalepa, Jill Barnholtz-Sloan, Rikki Enzor, et al.
American Journal of Medical Genetics. Part A
|
July 24, 2012
The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research
Maria T Acosta, Carrie E Bearden, F Xavier Castellanos, et al.
Cell Chemical Biology
|
February 9, 2023
Selective and brain-penetrant lanosterol synthase inhibitors target glioma stem-like cells by inducing 24(S),25-epoxycholesterol production
Thu P Nguyen, Wentian Wang, Alex C Sternisha, et al.
Cell
|
November 6, 2008
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow
Feng-Chun Yang, David A Ingram, Shi Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 10, 2025
Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors
Sameer Farouk Sait, Kwan Ho Tang, Steven P Angus, et al.
Nature
|
November 20, 2024
Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma
Yu-Jung Chen, Swathi V Iyer, David Chun-Cheng Hsieh, et al.
American Journal of Medical Genetics. Part A
|
November 14, 2014
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues
Katherine A Rauen, Susan M Huson, Emma Burkitt-Wright, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation
Laura Biddlestone-Thorpe, Muhammad Sajjad, Elizabeth Rosenberg, et al.
American Journal of Medical Genetics. Part A
|
January 29, 2011
Back to the future: proceedings from the 2010 NF Conference
Susan M Huson, Maria T Acosta, Allan J Belzberg, et al.
Page
of 14